Author Index: B
• PREDICTING THE HUI3 AND EQ-5D FROM THE MOS-HIV IN PATIENTS WITH ADVANCED HIV
• THE COST-EFFECTIVENESS OF A DECISION AID FOR PATIENTS CONSIDERING TOTAL HIP OR KNEE ARTHROPLASTY: SUB-ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
• AVERSION TO AMBIGUITY ABOUT THE RISK OF TREATMENT HARMS INFLUENCES DECISION MAKING AND VARIES BY LEVEL OF RISK AND AMBIGUITY
• WHAT IS THE IMPACT OF DESCRIBING TREATMENTS AS 'NEW'?
• CHOOSING TREATMENTS CONGRUENT WITH VALUES: DO PATIENTS NEED HELP AND DO DECISION AIDS PROVIDE IT? SUB-ANALYSIS OF A SYSTEMATIC REVIEW
• THE COST-EFFECTIVENESS OF A DECISION AID FOR PATIENTS CONSIDERING TOTAL HIP OR KNEE ARTHROPLASTY: SUB-ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
• AVERSION TO AMBIGUITY ABOUT THE RISK OF TREATMENT HARMS INFLUENCES DECISION MAKING AND VARIES BY LEVEL OF RISK AND AMBIGUITY
• WHAT IS THE IMPACT OF DESCRIBING TREATMENTS AS 'NEW'?
• CHOOSING TREATMENTS CONGRUENT WITH VALUES: DO PATIENTS NEED HELP AND DO DECISION AIDS PROVIDE IT? SUB-ANALYSIS OF A SYSTEMATIC REVIEW
• A FRAMEWORK FOR PRIORITIZING RESEARCH INVESTMENTS IN PRECISION MEDICINE
• ASSESSING THE IMPACT OF RECENCY EFFECT IN SURGERY
• NOT MY CHILD: DOES OPTIMISM BIAS INFLUENCE PARENT PREDICTIONS OF CHILDHOOD-OBESITY RELATED DISEASE RISKS?
• PORTFOLIO MANAGEMENT TO INFORM CANCER CLINICAL TRIALS RESEARCH INVESTMENT DECISIONS IN THE US: A PROOF OF CONCEPT EVALUATION
• ASSESSING THE IMPACT OF RECENCY EFFECT IN SURGERY
• NOT MY CHILD: DOES OPTIMISM BIAS INFLUENCE PARENT PREDICTIONS OF CHILDHOOD-OBESITY RELATED DISEASE RISKS?
• PORTFOLIO MANAGEMENT TO INFORM CANCER CLINICAL TRIALS RESEARCH INVESTMENT DECISIONS IN THE US: A PROOF OF CONCEPT EVALUATION
• IMPACT OF EXPANDING THE NATIONAL SALT REDUCTION INITIATIVE: A MATHEMATICAL MODEL OF BENEFITS AND RISKS OF POPULATION-LEVEL SODIUM REDUCTION
• MODELING EMERGENCY DEPARTMENT UTILIZATION
• USING DECOMPOSITION ANALYSIS TO UNDERSTAND THE IMPACT OF SODIUM ON DISPARITIES IN BLOOD PRESSURE IN THE UNITED STATES
• MODELING EMERGENCY DEPARTMENT UTILIZATION
• USING DECOMPOSITION ANALYSIS TO UNDERSTAND THE IMPACT OF SODIUM ON DISPARITIES IN BLOOD PRESSURE IN THE UNITED STATES
• DATA-DRIVEN MODELING AND SIMULATION FOR THE DESIGN AND EVALUATION OF HIV VIRAL LOAD MONITORING POLICIES IN RESOURCE-LIMITED SETTINGS
• COST-EFFECTIVENESS OF HIV PREEXPOSURE PROPHYLAXIS FOR INJECTION DRUG USERS IN THE UNITED STATES
• EFFECT OF CORN PRICE ON MEAT CONSUMPTION AND HEALTH OUTCOMES IN BALTIMORE CITY
• COST-EFFECTIVENESS OF HIV PREEXPOSURE PROPHYLAXIS FOR INJECTION DRUG USERS IN THE UNITED STATES
• EFFECT OF CORN PRICE ON MEAT CONSUMPTION AND HEALTH OUTCOMES IN BALTIMORE CITY
• SHARED DECISION MAKING (SDM) IN PEDIATRIC TYPE 1 DIABETES: EVALUATION OF DECISION COACHING WITH A PATIENT DECISION AID
• BARRIERS AND FACILITATORS OF IMPLEMENTING SHARED DECISION MAKING AND DECISION SUPPORT IN A PEDIATRIC HOSPITAL: A DESCRIPTIVE STUDY
• PARENTAL DECISION MAKING INVOLVEMENT AND DECISIONAL CONFLICT: A DESCRIPTIVE STUDY
• EVALUATING A WORKSHOP TO DEVELOP SHARED DECISION MAKING AND DECISION COACHING SKILLS AMONGST PEDIATRIC HEALTHCARE PROFESSIONALS
• BARRIERS AND FACILITATORS OF IMPLEMENTING SHARED DECISION MAKING AND DECISION SUPPORT IN A PEDIATRIC HOSPITAL: A DESCRIPTIVE STUDY
• PARENTAL DECISION MAKING INVOLVEMENT AND DECISIONAL CONFLICT: A DESCRIPTIVE STUDY
• EVALUATING A WORKSHOP TO DEVELOP SHARED DECISION MAKING AND DECISION COACHING SKILLS AMONGST PEDIATRIC HEALTHCARE PROFESSIONALS
• DISTINGUISHING HIGH-RISK VERSUS LOW-RISK SUBGROUPS IN COMPARTMENTAL EPIDEMIC MODELS: WHERE TO DRAW THE LINE?
• OPTIMAL TIMING OF DRUG SENSITIVITY TESTING FOR PATIENTS ON FIRST-LINE TB TREATMENT IN INDIA
• IMPACT OF EXPANDING THE NATIONAL SALT REDUCTION INITIATIVE: A MATHEMATICAL MODEL OF BENEFITS AND RISKS OF POPULATION-LEVEL SODIUM REDUCTION
• COST-EFFECTIVENESS OF HIV PREEXPOSURE PROPHYLAXIS FOR INJECTION DRUG USERS IN THE UNITED STATES
• OPTIMAL TIMING OF DRUG SENSITIVITY TESTING FOR PATIENTS ON FIRST-LINE TB TREATMENT IN INDIA
• IMPACT OF EXPANDING THE NATIONAL SALT REDUCTION INITIATIVE: A MATHEMATICAL MODEL OF BENEFITS AND RISKS OF POPULATION-LEVEL SODIUM REDUCTION
• COST-EFFECTIVENESS OF HIV PREEXPOSURE PROPHYLAXIS FOR INJECTION DRUG USERS IN THE UNITED STATES
• PREDICTING UTILITY SCORES FOR MYELOFIBROSIS PATIENTS: MAPPING THE MYELOFIBROSIS SYMPTOM ASSESSMENT FORM AND MYELOPROLIFERATIVE SYMPTOM ASSESSMENT FORM TO THE EUROQOL-5D
• HEALTH UTILITIES IN MARGINALIZED CHRONIC HEPATITIS C PATIENTS PARTICIPATING IN A COMMUNITY-BASED HEPATITIS C PROGRAM
• SOCIAL MEDIA AS A KEY TOOL TO RECRUIT RARE DISEASE PATIENTS FOR CLINICAL RESEARCHERS
• HEALTH UTILITIES IN MARGINALIZED CHRONIC HEPATITIS C PATIENTS PARTICIPATING IN A COMMUNITY-BASED HEPATITIS C PROGRAM
• SOCIAL MEDIA AS A KEY TOOL TO RECRUIT RARE DISEASE PATIENTS FOR CLINICAL RESEARCHERS
• RANDOMIZED TRIAL OF A DECISION AID TO PROMOTE APPROPRIATE COLORECTAL CANCER SCREENING AMONG OLDER ADULTS
• INFLUENCES ON PRIMARY CARE PROVIDERS' RECOMMENDATIONS FOR HYPOTHETICAL PROSTATE AND COLON CANCER SCREENING IN OLDER ADULTS: A WITHIN-SUBJECTS EXPERIMENT
• WHAT LEADS PARENTS TO SAY YES, NO OR MAYBE TO HUMAN PAPILLOMAVIRUS VACCINATION? THE ROLE OF PROVIDER RECOMMENDATION QUALITY
• INFLUENCES ON PRIMARY CARE PROVIDERS' RECOMMENDATIONS FOR HYPOTHETICAL PROSTATE AND COLON CANCER SCREENING IN OLDER ADULTS: A WITHIN-SUBJECTS EXPERIMENT
• WHAT LEADS PARENTS TO SAY YES, NO OR MAYBE TO HUMAN PAPILLOMAVIRUS VACCINATION? THE ROLE OF PROVIDER RECOMMENDATION QUALITY
• VARIATION IN CAREGIVER PREFERENCES FOR PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENTS: A COMPARISON OF STRATIFICATION AND LATENT CLASS ANALYSIS
• USE OF BEST-WORST SCALING TO ASSESS PATIENT PREFERENCES FOR REFRACTORY OVERACTIVE BLADDER TREATMENTS
• SYMPOSIUM: TRANSLATING PATIENT PREFERENCE RESEARCH INTO REGULATORY PRACTICE
• DEVELOPING A STATED-PREFERENCES INSTRUMENT FOR DUCHENNE/BECKER MUSCULAR DYSTROPHY– A COMMUNITY-ENGAGED RESEARCH APPLICATION
• A BEGINNERS’ GUIDE TO THE ART AND SCIENCE OF STATED-PREFERENCE METHODS
• DO STAKEHOLDER PREFERENCES FOR ENGAGEMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENT CORRELATE WITH REPORTED OUTCOMES? A BEST WORST SCALING EXPERIMENT
• USE OF BEST-WORST SCALING TO ASSESS PATIENT PREFERENCES FOR REFRACTORY OVERACTIVE BLADDER TREATMENTS
• SYMPOSIUM: TRANSLATING PATIENT PREFERENCE RESEARCH INTO REGULATORY PRACTICE
• DEVELOPING A STATED-PREFERENCES INSTRUMENT FOR DUCHENNE/BECKER MUSCULAR DYSTROPHY– A COMMUNITY-ENGAGED RESEARCH APPLICATION
• A BEGINNERS’ GUIDE TO THE ART AND SCIENCE OF STATED-PREFERENCE METHODS
• DO STAKEHOLDER PREFERENCES FOR ENGAGEMENT IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER TREATMENT CORRELATE WITH REPORTED OUTCOMES? A BEST WORST SCALING EXPERIMENT